Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd

Christoph K. Stein-Thoeringer, MD, Jonathan U. Peled, MD PhD, Antonio LC Gomes, PhD, Amina Lazrak, BS, Melissa D Docampo, BS, Ann E. Slingerland, BSc, Katherine Nichols, BS, Yusuke Shono, MD PhD, Daniela Weber, MD, Anthony D. Sung, MD, Daigo Hashimoto, MD, PhD, Justin Cross, PhD, Takanori Teshima, Ernst Holler, MD, Nelson J. Chao, MD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2018) 132 (Supplement 1): 358.

https://doi.org/10.1182/blood-2018-99-119887

Published: 2018

Journal Articles

Nrf2 Is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease

Jennifer Tsai, MD PhD, Enrico Velardi, PhD BS, Yusuke Shono, MD PhD, Kimon Argyropoulos, MD, Odette M. Smith, BA, Amina Lazrak, BS, Chen Liu, MD PhD, George F Murphy, MD, Ya-Yuan Fu, PhD, Alan M. Hanash, Robert R. Jenq, MD, Jarrod A Dudakov, PhD, Marcel R.M. van den Brink, MD PhD

Blood (2017) 130 (Supplement 1): 205.

https://doi.org/10.1182/blood.V130.Suppl_1.205.205

Published: 2017

Journal Articles

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone-Marrow Transplantation in Mice

Anna Staffas, PhD MSc, Marina Burgos da Silva, PhD, Ann E. Slingerland, BS, Amina Lazrak, BS, Yusuke Shono, MD PhD, Benjamin H Durham, MD BS, Christoph K. Stein-Thoeringer, MD, Melissa Docampo, Hillary V. Jay, Sophia R. Lieberman, Odette M. Smith, BA, Eric G. Pamer, MD, Jonathan U. Peled, MD, Robert R. Jenq, MD, Marcel R.M. van den Brink, MD PhD

Blood (2017) 130 (Supplement 1): 1899.

https://doi.org/10.1182/blood.V130.Suppl_1.1899.1899

Published: 2017

Journal Articles

Pharmacological Inhibition of Luteinizing Hormone Signaling Promotes HSC Quiescence and Hematopoietic Regeneration

Enrico Velardi, PhD BS, Jennifer Tsai, MD PhD, Stefan Radtke, PhD, Kirsten Cooper, Kimon Argyropoulos, MD, Shieh Jae-Hung, PhD, Yusuke Shono, MD PhD, Robert R. Jenq, MD, Alan M. Hanash, Malcolm A.S. Moore, DPhil, Hans-Peter Kiem, MD PhD, Marcel R.M. van den Brink, MD PhD, Jarrod A Dudakov, PhD

Blood (2017) 130 (Supplement 1): 1139.

https://doi.org/10.1182/blood.V130.Suppl_1.1139.1139

Published: 2017

Journal Articles

Suppression of Luteinizing Hormone Enhances HSC Recovery after Hematopoietic Injuries

Enrico Velardi, PhD, Jennifer Jia-ying Tsai, PhD, Kimon V. Argyropoulos, MD, Shieh Jae-Hung, Sophie Lieberman, Fabiana Kreines, Yusuke Shono, MD PhD, Lauren Young, Tobias Wertheimer, Robert R. Jenq, MD, Alan M Hanash, MD PhD, Malcolm A.S. Moore, PhD, Marcel Van Den Brink, MD PhD, Jarrod A Dudakov, PhD

Blood (2016) 128 (22): 370.

https://doi.org/10.1182/blood.V128.22.370.370

Published: 2016

Journal Articles

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Yusuke Shono, MD PhD, Melissa D. Docampo, Odette M. Smith, Jyotsna Gupta, Sophia R. Liberman, Ying Taur, MD, Kenya Honda, MD PhD, Marcel R.M. van den Brink, MD PhD, Robert R. Jenq, MD

Blood (2014) 124 (21): 186.

https://doi.org/10.1182/blood.V124.21.186.186

Published: 2014

Journal Articles

Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel

Yusuke Shono, MD PhD, Andrea Z. Tuckett, PhD, Hsiou-Chi Liou, PhD, Samedy Ouk, PhD, Ekaterina Doubrovina, MD PhD, Mikhail Doubrovin, MD PhD, Enrico Derenzini, MD, Mary I. Scallion, BS, Jennifer J. Tsai, MD, Odette M. Smith, Anas Younes, MD PhD, Richard J. O'Reilly, MD PhD, Marcel R.M. van den Brink, MD PhD, Johannes L. Zakrzewski, MD

Blood (2014) 124 (21): 507.

https://doi.org/10.1182/blood.V124.21.507.507

Published: 2014

Journal Articles

Inhibition of c-Rel Signaling: A Novel Small Molecule-Based Therapy Diminishing T Cell Alloactivation While Preserving Anti-Tumor Activity

Yusuke Shono, MD, PhD, Andrea Tuckett, PhD, Hsiou-Chi Liou, PhD, Gregoire Atlan-Bonnet, PhD, Jennifer J. Tsai, M.D., Odette M. Smith, BA, Mallory L. West, BS, Natalie V. Singer, BS, Marcel R.M. van den Brink, MD, PhD, Johannes Zakrzewski, MD

Blood (2012) 120 (21): 454.

https://doi.org/10.1182/blood.V120.21.454.454

Published: 2012

Journal Articles

CD19-Targeted Donor T Cells Exert Potent Graft Versus Lymphoma Activity and Attenuated Gvhd

Arnab Ghosh, MD, PhD, Marco L. Davila, MD, PhD, Lauren F. Young, BS, Christopher Kloss, BS, Gertrude Gunset, BS, Odette M. Smith, BA, Mallory L. West, BS, Natalie V. Singer, BS, Amanda M. Holland, BS, Robert R. Jenq, MD, Alan M. Hanash, MD, PhD, Jarrod A. Dudakov, PhD, Enrico Velardi, PhD, Yusuke Shono, MD, PhD, Michel Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2012) 120 (21): 451.

https://doi.org/10.1182/blood.V120.21.451.451

Published: 2012

Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Junji Tanaka, MD, PhD, Junichi Sugita, MD, Naoko Kato, MD, PhD, Tomomi Toubai, MD, PhD, Jun Ibata, MD, Yusuke Shono, MD, Shuichi Ota, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2006) 108 (11): 1739.

https://doi.org/10.1182/blood.V108.11.1739.1739

Published: 2006

NARROW

Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd

Nrf2 Is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone-Marrow Transplantation in Mice

Pharmacological Inhibition of Luteinizing Hormone Signaling Promotes HSC Quiescence and Hematopoietic Regeneration

Suppression of Luteinizing Hormone Enhances HSC Recovery after Hematopoietic Injuries

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel

Inhibition of c-Rel Signaling: A Novel Small Molecule-Based Therapy Diminishing T Cell Alloactivation While Preserving Anti-Tumor Activity

CD19-Targeted Donor T Cells Exert Potent Graft Versus Lymphoma Activity and Attenuated Gvhd

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing Cytolytic CD8 T Cells and CD4 + CD25 + Regulatory T Cells from the Same Cord Blood.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only